Related Experiment Video
Updated: Aug 10, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Insulin-like growth factor-I in men with idiopathic osteoporosis
E S Kurland1, C J Rosen, F Cosman
1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, N.Y. 10032, USA.
Abstract:
The etiology of osteoporosis in most men without a history of alcohol abuse, hypogonadism, or glucocorticoid excess is unknown. Several histomorphometric reports have demonstrated a reduction in indices of bone formation. We tested the hypothesis that the putative reduction in bone formation in men with idiopathic osteoporosis may be related to deficiencies in skeletal mechanisms that are mediated by insulin-like growth factor I (IGF-I). Twenty-four middle-aged men (50.5 +/- 1.9 yr) with severe idiopathic osteoporosis (mean lumbar spine T-score -3.5 +/- 0.16) were studied. The following biochemical indices were all normal: serum calcium, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, testosterone, osteocalcin, carboxyterminal propeptide of type I collagen, bone specific alkaline phosphatase, urinary calcium, and collagen crosslinks. Parathyroid hormone level was in the lower range of normal, 25 +/- 2 pg/mL (nl: 10-65). Mean serum IGF-I level was also in the lower range of normal, 157.9 +/- 7.6 ng/mL (normal age-matched range, 140-260 ng/mL). Eight men had IGF-I levels that were below 140 ng/mL. The mean IGF-IZ score was -0.75, significantly different from the expected mean of zero (P = 0.0002). IGF-I was correlated negatively with age (r = -0.49, P < 0.02). With age held constant, serum IGF-I accounted for 15% of the variance in lumbar bone mineral density (BMD; P < 0.001). The osteocalcin concentration correlated well with bone density at the distal 1/3 radius (r = +0.44; P < 0.002). Histomorphometric analysis of bone biopsy specimens showed significant reductions in cancellous bone volume (31%; P < 0.001), cortical width (28%; P < 0.05), osteoid surface (33%; P < 0.01), and bone formation rate (54%; P < 0.01) when results were compared with age-matched control subjects. Percent eroded surface was normal and was correlated inversely with serum IGF-I levels (r = -0.5; P < 0.04). These results suggest that serum IGF-I levels are reduced in men with idiopathic osteoporosis and that IGF-I correlates with and may contribute to the reduction in lumbar spine bone mass density (BMD). The low IGF-I levels may reflect the reduction in bone formation demonstrated by histomorphometry. Insights into the etiology of idiopathic osteoporosis in men may be revealed by further studies of the IGF-I axis.
Insights
Idiopathic osteoporosis in men may be linked to low insulin-like growth factor I (IGF-I) levels, which correlate with reduced bone formation and bone mineral density (BMD). Further research into the IGF-I axis is warranted.
Area of Science:
- Endocrinology
- Bone Biology
- Gerontology
Background:
- The cause of osteoporosis in men without known risk factors like alcohol abuse or hormonal imbalances is often unclear.
- Previous studies suggest reduced bone formation in idiopathic osteoporosis.
- Insulin-like growth factor I (IGF-I) plays a role in skeletal health.
Purpose of the Study:
- To investigate if reduced bone formation in men with idiopathic osteoporosis is associated with deficiencies in IGF-I mediated skeletal mechanisms.
- To examine the relationship between serum IGF-I levels and bone mineral density (BMD) in middle-aged men with severe idiopathic osteoporosis.
Main Methods:
- Studied 24 middle-aged men with severe idiopathic osteoporosis, assessing various biochemical indices and bone mineral density.
- Performed histomorphometric analysis on bone biopsy specimens.
- Correlated serum IGF-I levels with age, BMD, and bone formation/resorption markers.
Main Results:
- Men with idiopathic osteoporosis had normal levels of most tested biochemical markers, but some had low-normal parathyroid hormone and serum IGF-I levels.
- Serum IGF-I levels were negatively correlated with age and positively with lumbar spine BMD.
- Histomorphometry revealed significant reductions in cancellous bone volume, cortical width, osteoid surface, and bone formation rate compared to controls.
Conclusions:
- Serum IGF-I levels are reduced in men with idiopathic osteoporosis and correlate with reduced bone mass and bone formation.
- Low IGF-I may contribute to the pathogenesis of idiopathic osteoporosis in men.
- The IGF-I axis is a potential area for further investigation into the etiology of male osteoporosis.
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
